Students from kindergarten through 12th grade have a unique opportunity tonight at the Fox Theater. The Future Song ...

Forever 21 has filed for bankruptcy for the second time in six years. The retailer's U.S. operating company made the filing ...

When each death relies on characters who have already suffered tenfold, it's impossible not to feel nauseated each time someone is picked off.

At least 100,000 people have converged in Belgrade for a massive rally in the Serbian capital seen as a culmination of months-long protests against populist President Aleksandar Vucic. Tens of ...

El acorde de Come Into My World (Radio Edit) de Kylie Minogue es una versi�n de la canci�n original realizada por ...

Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses regulatory challenges for DB-OTO, Regeneron’s AAV-based gene therapy for hearing loss.

Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses how key regulatory designations, such as the FDA's Regenerative Medicine Advanced Therapy designation, facilitate ...

Over 6 million rail customers in Germany filed for compensation over delays and cancellations. Germany's rail operator said old and overloaded infrastructure was to ...

Leonardo SpA, the Italian defense and aerospace company, has replaced Bank of America Corp. with Deutsche Bank AG to advise on talks to forge a new European space and satellite champion, according to ...

An updated version of this story is available here. An off-duty firefighter was drunk and high when he flew down Northern Boulevard at 83 mph and slammed into another car, killing the man at the ...

Ten children who received DB-OTO for profound genetic hearing loss due to variants of the otoferlin gene showed notable improvements in hearing, according to initial results of the CHORD trial.

TARRYTOWN, N.Y., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced updated data for the investigational gene therapy DB-OTO from the Phase 1/2 CHORD ...